TELA Bio, Inc. (TELA)
NASDAQ: TELA · Real-Time Price · USD
1.170
-0.010 (-0.85%)
At close: Nov 7, 2025, 4:00 PM EST
1.190
+0.020 (1.71%)
After-hours: Nov 7, 2025, 6:57 PM EST
TELA Bio Market Cap
TELA Bio has a market cap or net worth of $46.35 million as of November 7, 2025. Its market cap has decreased by -29.23% in one year.
Market Cap
46.35M
Enterprise Value
54.52M
1-Year Change
-29.23%
Ranking
Category
Stock Price
$1.17
Market Cap Chart
Since November 8, 2019, TELA Bio's market cap has decreased from $146.94M to $46.35M, a decrease of -68.46%. That is a compound annual growth rate of -17.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 7, 2025 | 46.35M | -61.03% |
| Dec 31, 2024 | 118.95M | -26.62% |
| Dec 29, 2023 | 162.12M | -26.42% |
| Dec 30, 2022 | 220.33M | 18.68% |
| Dec 31, 2021 | 185.65M | -14.47% |
| Dec 31, 2020 | 217.06M | 46.96% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 8, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 809.87B |
| Johnson & Johnson | 450.51B |
| AbbVie | 385.43B |
| UnitedHealth Group | 288.42B |
| AstraZeneca | 260.82B |
| Novartis AG | 242.27B |
| Abbott Laboratories | 218.21B |
| Merck & Co. | 214.20B |